What's next for biomedical research – Future Investment Initiative 2019 – Day 2

Sam Kulkarni, CEO of CRISPR Therapeutics AG, discussed how advancements in gene editing and cellular therapies are revolutionizing biomedical research and driving game-changing medical breakthroughs at #FII2019.